Main competitors
Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Capi.($)
- - - - - - - 47Cr
0.75%0.84%37.1x27.25x12.29x28.04x30.16x 71TCr
3.33%3.42%15.11x5.07x4.18x11.51x12.78x 38TCr
3.37%3.52%27.63x48.8x6.67x13.94x14.39x 34TCr
2.9%3.37%17.47x9.87x6.3x12.57x13.89x 32TCr
3.75%3.84%14.5x5.52x3.56x8.79x10.09x 26TCr
3.16%3.31%17.66x5.26x4.77x11.53x12.59x 24TCr
2.23%2.34%22.78x4.96x4.24x12.47x13.21x 22TCr
3.83%4.02%10.76x3.8x3.49x7.54x8.4x 21TCr
3.19%3.36%22.85x18.17x5.86x11.37x13.29x 16TCr
6.63%6.76%12.19x1.61x2.96x7.33x8.48x 15TCr
2.84%2.97%21.04x6.36x5.37x9.81x11.82x 14TCr
-.--%-.--%31.89x6.23x9.51x20.01x21.03x 12TCr
4.92%5.19%11.79x1.31x2.44x7.98x8.74x 12TCr
5.11%5.28%10.92x4.69x2.85x7.56x8.05x 9.87TCr
4.47%4.75%10.22x3.97x2.25x6.67x7.65x 7.98TCr
3.67%1.73%25.89x5.64x8.6x16.92x17.7x 7.71TCr
0.4%0.46%50.45x6.87x11.16x40.85x44.58x 5.36TCr
4.61%4.7%27.85x1x2.33x8.58x21.64x 4.68TCr
Average 3.29% 3.33% 21.56x 9.24x 5.49x 13.53x 15.47x 19.7TCr
Weighted average by Cap. 2.89% 3% 22.53x 14.02x 6.37x 14.82x 16.29x
Other Pharmaceuticals